Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 7.


McEwan, Phil, Bennett, Hayley, Khunti, Kamlesh, Wilding, John ORCID: 0000-0003-2839-8404, Edmonds, Christopher, Thuresson, Marcus, Wittbrodt, Eric, Fenici, Peter and Kosiborod, Mikhail
(2020) Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence. DIABETES OBESITY & METABOLISM, 22 (12). 2364 - 2374.


Kosiborod, Mikhail, Lam, Carolyn SP, Kohsaka, Shun, Kim, Dae Jung, Karasik, Avraham, Shaw, Jonathan, Tangri, Navdeep, Goh, Su-Yen, Thuresson, Marcus, Chen, Hungta
et al (show 58 more authors) (2018) Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study. Journal of the American College of Cardiology, 71 (23). 2628 - 2639.


Wilding, John ORCID: 0000-0003-2839-8404, Godec, Thomas, Khunti, Kamlesh, Pocock, Stuart, Fox, Robin, Smeeth, Liam, Clauson, Per, Fenici, Peter, Hammar, Niklas and Medina, Jesús
(2018) Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Medicine, 16.


Clift, Ash K, Coupland, Carol AC, Keogh, Ruth H, Diaz-Ordaz, Karla, Williamson, Elizabeth, Harrison, Ewen M, Hayward, Andrew, Hemingway, Harry, Horby, Peter, Mehta, Nisha
et al (show 13 more authors) (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ-BRITISH MEDICAL JOURNAL, 371.


Kosiborod, Mikhail, Birkeland, Kare I, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Jorgensen, Marit E, Wittbrodt, Eric T
et al (show 5 more authors) (2018) Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study. DIABETES OBESITY & METABOLISM, 20 (8). 1983 - 1987.


Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Thuresson, Marcus
et al (show 5 more authors) (2018) Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". CIRCULATION, 137 (9). 989 - 991.


Cavender, Matthew A, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Fu, Alex Z, Bodegard, Johan, Blak, Betina T, Wittbrodt, Eric
et al (show 5 more authors) (2018) SGLT-2 Inhibitors and Cardiovascular Risk An Analysis of CVD-REAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 71 (22). 2497 - 2506.

This list was generated on Sat Nov 28 18:23:11 2020 GMT.